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1. Introduction 
The carcinogens N-acetoxy-2-acetylamino- 
fluorene ((Ac)aONFln) and IV-methyl-Ar-nitrosourea 
(MeNOUr) bind covalently to duplex DNA in vivo 
and in vitro [ 1,2]. MeNOUr predominantly methyl- 
ates guanine bases in the N-7 (60%) and O6 (8%) 
position, adenine in the N-3 (8%) position and phos- 
phorus oxygen (25%) [3]. (Ac)zONFln substitutes 
H-8 of guanine by the N-2-fluorenylacetamido 
residue and to a minor extent N2-H of guanine by 
the 2-acetylaminofluorenyl residue [l] . Substitution 
of H-8 forces the base to rotate from the normal 
anti to the syn conformation thus causing steric dis- 
tortions and localized denaturation of the double 
helix [4]. 
The above alterations have been shown to affect 
the biological activity of nucleic acids by inducing 
mutation and malignant cell transformation [ 1,5,6] , 
termination of transcription [7] or inactivation of 
phage @X-DNA for transfection [8]. 
Single-stranded DNA is particularly prone to the 
attack of carcinogens as functional groups required 
for hydrogen bonding are exposed in addition to the 
nucleophilic sites of the helix. Therefore, when 
tested for template activity, carcinogen-modified 
single-stranded DNA should show diminished ability 
for base pairing, which could result in a block of DNA 
synthesis. 
An in vitro DNA-replicating system [9] which uses 
Abbreviations: (Ac),ONFln, N-acetoxy-2-acetylaminofluorene; 
MeNOUr, N-methyl-N-nitrosourea; DNA binding protein I is 
from E. coli and was formerly named DNA unwinding protein 
[14,151 
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RNA-primed single-stranded phage fd DNA and 
E. coli DNA polymerase Ill holoenzyme or DNA 
polymerase I appeared to be sensitive enough to 
prove this point. The present study will show that the 
carcinogen (Ac)20NFln is capable of drastically 
inhibiting DNA synthesis. This inhibition is less pro- 
nounced, when single-stranded DNA is chemically 
modified in the presence of the DNA binding protein I. 
MeNOUr also causes inhibition, although at higher 
concentrations. DNA binding protein I is less effective 
in protecting the DNA template against methylation 
than against arylamidation. 
2. Materials and methods 
N-acetoxy-2-acetylaminofluorene (MW 281) [lo] 
and IV-methyl-llr-nitrosourea (MW 103) [ 1 l] were 
prepared according to published methods. DNA poly- 
merase Ill holoenzyme was partially purified by a 
modification of the first steps in [ 121, DNA poly- 
merase I by the modified procedure in [ 131. The 
purification of E. coli DNA binding protein I [ 141 
was published [ 151. 
The carcinogens were freshly dissolved and 
diluted in dimethylsulfoxide (Me2SO), further diluted 
in buffer Cl00 [9] which is 10% glycerol, 20 mM 
Tris-HCl, pH 7.5,0.2 mM EDTA, 1 mM mercapto- 
ethanol and 100 mM NaCl. Aliquots were immediately 
added to RNA-primed single-stranded phage fd DNA 
(400 pmol deoxynucleotides). Unless stated otherwise, 
the mixture (15 /JL) was incubated for 30 min 
((Ac)20NFln) or 10 min (MeNOUr) at 3O”C, and then 
DNA polymerase, deoxynucleoside triphosphates 
(at 50 PM; the cY-32P-labelled dTTP at 25 PM), MgC12 
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at 5 mM, spermidine at 3 mM or DNA binding 
protein I(2 pg/assay) were added to final vol. 20 ~1. 
Incubation was continued for 10 min (DNA poly- 
merase III holoenzyme) or 30 min (DNA polymerase I), 
and the mixture precipitated with 7% perchloric 
acid, filtered and the nitrocellulose filter counted in a 
gas flow counter. About 80 pmol deoxynucleotides 
were incorporated on the template in the control 
experiment without inhibition. 
3. Results 
Binding of (Ac)*ONFln to single-stranded DNA 




Fig.1. Time-dependent interaction of (Ac),ONFln (60 NM; 
20 rg/ml) with RNA-primed fdDNA: after incubation of 
the DNA with carcinogen at 30°C for the time indicated 
DNA polymerase III holoenzyme and deoxynucleoside 
triphosphates were added and the mixture incubated for 
additional 10 min. 
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Flg.2. Inhibition of DNA synthesis with increasing amounts 
of (Ac),ONFln. RNA-primed fd DNA was preincubated 
with the carcinogen for 30 min at 3O’C. Then DNA synthesis 
in the presence of spermidine (3 mM) with DNA poly- 
merase III holoenzyme (A: o-0) or DNA polymerase I 
(B: A-A) was allowed for 10 or 30 min, respectively. For 
the lower curve (C: o-o) 2 fig DNA binding protein I were 
added fust, followed by the preincubation with carcinogen 
for 30 min, and finally 10 min DNA synthesis with DNA 
polymerase III holoenzyme was allowed. 
investigated for DNA polymerase I and III holo- 
enzyme from E. coli. The reaction of (Ac),ONFln 
with RNA-primed single-stranded fd DNA is a time- 
requiring process (fig.1). Thus inhibition of DNA 
polymerase III holoenzyme was found to be 85% 
when RNA-primed single-stranded fd DNA was 
preincubated with the carcinogen for 1 h as com- 
pared to 12%, when carcinogen, DNA polymerase III 
holoenzyme and deoxynucleoside triphosphates 
were added simultaneously. 
Preincubation of RNA-primed single-stranded fd 
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DNA with increasing concentrations of (Ac)20NFln 
resulted in increasing inhibition of DNA synthesis 
(tig.2). An inhibition of 50% could be achieved for 
DNA polymerase III holoenzyme at 5 PM (Ac)20NFln 
in the incubation mixture (curve A). DNA poly- 
merase I was less inhibited at the same carcinogen 
concentration (curve B). Complex formation of fd 
DNA with the DNA-binding protein I prior to the 
addition of (Ac)*ONFln (15 PM) led to reduction of 
DNA synthesis of only 7% compared to 75% in the 
assay with free DNA (curve A,C). 
MeNOUr was also capable of slowing down the 
rate of DNA synthesis. The extent of inhibition 
depended upon the MeNOUr concentration fd DNA 
was exposed to (fig.3). Preincubation of the RNA- 
primed DNA template in a 10 mM solution of 
MeNOUr for 10 min led to 70% inhibition, whereas 
26% inhibition was measured, when DNA polymeri- 
zation was allowed to proceed immediately after 
addition of the alkylating carcinogen. Extension of 
the incubation time beyond 10 min did not result in 
markedly increased inhibition of DNA synthesis (data 
not shown). DNA polymerase III holoenzyme (fig.3, 
curve A) is slightly more sensitive to MeNOUr than 
DNA polymerase I (curve B). 
As judged from the rate of DNA synthesis, com- 
plexation of the template with the DNA binding 
protein I prior to the application of MeNOUr was 
little effective in preventing methylation (Bg.3, 
curve C). 
Methylation of guanine at O6 and fluorenylation 
at N2 interfere with base pairing. (Ac)20NFln, how- 
ever, causes an additional inhibitory effect on DNA 
synthesis, since arylamidation of C-8 of guanine 
sterically alters single-stranded DNA to an extent as to 
make formation of a normal double-helical structure 
impossible. It is thus not surprising that 50% inhibition 
of the DNA polymerases by (Ac)?ONFln was found 
at an about lOOO-fold lower concentration than 
required for MeNOUr (tig.2,3). 
None of the carcinogen-modified templates used 
in the above experiments showed strand breaks when 
analysed by velocity sedimentation in neutral sucrose. 
4. Discussion 
Possibly one of the initiating steps in chemical 
carcinogenesis is transfer of electrophilic groups from 
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Fig.3. Inhibition of DNA synthesis by MeNOUr. The 
carcinogen was incubated with RNA-primed fd DNA for 
10 min at 3O”C, and DNA polymerase, spermidine or DNA 
binding protein I were added as described in fig.2. In controls 
Me,SO was added in the same concentration as required for 
the carcinogen. Some inhibition of DNA polymerase III 
holoenzyme was found at concentrations of more than 10% 
Me,SO. A (e-e), DNA polymerase III holoenzyme; B (A-A), 
DNA polymerase I; C (o-o) DNA binding protein I and 
DNA polymerase III holoenzyme. 
carcinogens to DNA. The replication fork is especially 
exposed as target for mutagens [ 161. Eukaryotic 
DNA polymerases lack fidelity in the presence of 
carcinogens [ 171. Chemical alterations of the helix 
as well as steric distortions resulting from covalent 
fixation of carcinogenic residues have been shown to 
give rise to repair [ 10,l l] . Persistence of the DNA 
damage during replication may cause the newly 
synthesized strand to be terminated at the site of the 
damage and to be resumed at an initiation site beyond, 
leaving a post-replication gap [ 181. Indeed, both 
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carcinogens caused DNA polymerase to discontinue 
DNA synthesis. Filling of the post-replication gap 
could result in insertions of non-complementary 
nucleotides thus giving rise to mutations. Such a 
mechanism leading eventually to transformation of 
a normal into a malignant cell can be postulated for 
MeNOUr [S] and for (Ac)aONFln [l] . 
Pronounced sensitivity of DNA synthesis towards 
(Ac)*ONFln was found (tig.2). A concentration range 
of 4-40 PM during preincubation proved to be 
sufficient for effective inhibition. Reversion of his 
mutants of Salmonella could be achieved at similarly 
low concentrations [19] , and single-stranded @X174- 
DNA was inactivated for transfection in the same 
range using carcinogens of comparable reactivity [8]. 
By contrast, DNA repair in ether-permeabilized E. coli 
cells required a 1 O-fold higher concentration of 
(Ac)zONFln [ lo] . 
MeNOUr had to be applied at a concentration of 
10 mM for maximal DNA repair [ 111 and also for 
more than 50% inhibition of DNA synthesis. This 
high level of MeNOUr compared to (Ac),ONFln 
might be due to differences in reactivity of the 
carcinogens towards DNA or due to the different 
potencies of the respective modified DNA sites to 
inhibit DNA polymerases. Thus, MeNOUr proved to 
be less biologically active by a factor of 1000. This 
difference may also be explainable by the fact that 
only 10% (06 of guanine and apurinic sites) of the 
total DNA methylation interfere with base pairing, 
whereas every arylamidated or fluorenylated site in 
single-stranded DNA is likely to make base pairing 
impossible. 
Carcinogens are especially potent on histone-free 
DNA [20]. Also phage fd DNA was protected against 
(Ac)aONFln by DNA binding protein I (fig.2) which 
indicates that carcinogens predominantly attack open 
DNA structures. 
Note added in proof 
Recently Hsu et al. (Proc. Nat1 Acad. Sci. USA 
(1977) 74,3335-3339) have shown that the carcinogen 
benzo[a] pyrene-7,8-dihydrodiol-9,10-epoxide inhibits 
the conversion of single-stranded phage 4X 174 DNA 
to replicative form DNA in soluble cell extracts. 
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